PTX3 was assayed at randomization and after 3 months in 1,233 patients from the GISSI-Heart Failure trial (GISSI-HF) and 1,457 patients from the Controlled Rosuvastatin Multinational Trial in HF (CORONA) (72). The gene discussed is PTX3; the disease is hydrops fetalis.